GlassScriptPhysician profile
Kirtida Nikunj Ringwala
NPI 1356376966
$5,733.48
in general payments reported to CMS, 2019-2025
36 companies · $601 in 2025
The $601 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $833 · 2020: $1,001 · 2021: $1,105 · 2022: $996 · 2023: $591 · 2024: $606 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,797.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,075.41 | 2019-2025 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $761.08 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $718.32 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $442.63 | 2019-2025 | Jardiance |
| Novo Nordisk INC | $321.03 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $312.60 | 2019-2024 | Trintellix, Gattex |
| Janssen Pharmaceuticals, INC | $274.76 | 2019-2021 | |
| Allergan, INC. | $204.98 | 2019-2020 | |
| Amgen INC. | $160.09 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $130.90 | 2019-2021 | |
| Pfizer INC. | $123.46 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $113.41 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $112.12 | 2021-2023 | |
| Amarin Pharma, INC. | $99.62 | 2019-2022 | |
| Alkermes, INC. | $80.41 | 2022-2023 | Aristada, Lybalvi |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirtida Ringwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.